![Cover Image for System.Linq.Enumerable+EnumerablePartition`1[System.Char]](https://coverimages.igi-global.com/images/search-article.png)
β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
An E Vanhaesebrouck, Richard Webster, Susan Maxwell, Pedro M Rodriguez Cruz, Judith Cossins, James Wickens, Wei-Wei Liu, Hakan Cetin, Jonathan Cheung, Hayley Ramjattan, Jacqueline Palace, David Beeson
OAI: oai:www.repository.cam.ac.uk:1810/298046 • DOI: 10.17863/CAM.45102
Abstract
AChR deficiency acetylcholinesterase inhibitor congenital myasthenic syndromes myasthenia β2-adrenergic Action Potentials Adrenergic beta-2 Receptor Agonists Albuterol Animals Cholinesterase Inhibitors Disease Models Animal Humans Mice Myasthenic Syndromes Congenital Neuromuscular Junction Pyridostigmine Bromide Synaptic Transmission